India hails 'life saving' Covid-19 vaccine rollout, but concerns remain about homegrown shot

Published January 17, 2021
Medical workers wait to be inoculated with a Covid-19 vaccine at a hospital in Allahabad on Saturday. — AFP
Medical workers wait to be inoculated with a Covid-19 vaccine at a hospital in Allahabad on Saturday. — AFP
A medical worker (L) registers the details of his colleague for a Covid-19 vaccine at the Institute of Kidney Diseases and Research Centre (IKDRC) in Ahmedabad on January 16. — AFP
A medical worker (L) registers the details of his colleague for a Covid-19 vaccine at the Institute of Kidney Diseases and Research Centre (IKDRC) in Ahmedabad on January 16. — AFP

India's Covid-19 vaccination drive had a successful start with more than 190,000 people receiving their first jabs and no one hospitalised for major side effects, the health ministry said, but reports emerged about concerns over the homegrown vaccine.

Authorities have given emergency-use approval for two vaccines — Oxford-AstraZeneca and the homegrown “Covaxin”, which has yet to complete its Phase 3 trials — and plans to immunise some 300 million people in the country of 1.3 billion by July.

Frontline workers such as hospital staff, people over 50 and those deemed to be at high risk due to pre-existing medical conditions are on the shortlist to receive the vaccines.

“We have got encouraging and satisfactory feedback results on the first day,” Health Minister Harsh Vardhan told his state counterparts on Saturday.

“This vaccine will indeed be a 'Sanjeevani' (lifesaver)” in the fight against the virus, he added.

The health ministry said “no case of post-vaccination hospitalisation” had been reported, although local media said a security guard at the country's top-ranked public hospital, the All India Institute of Medical Sciences (AIIMS) in Delhi, had developed an allergic reaction shortly after getting his shot.

A doctors' representative body at the Ram Manohar Lohia Hospital in New Delhi wrote a letter asking for the Oxford-AstraZeneca “Covishield” vaccine to be supplied instead of Covaxin to allay any fears.

“The residents are a bit apprehensive about the lack of complete trial in case of Covaxin and might not participate in huge numbers thus defeating the purpose of vaccination,” said the letter addressing the hospital's medical superintendent, seen by AFP.

“We request you to vaccinate us with Covishield, which has completed all stages of trial before its rollout.”

Pathologist Arvind Ahuja told AFP at the hospital on Saturday that he shared some of the concerns. “I hope when the data comes out, it is good. Ideally, they should have waited for one month at least as then we would have known better about its efficacy,” the 45-year-old said.

Vaccine hesitancy has emerged as a major concern, with a recent survey of 18,000 people across India finding that 69 per cent were in no rush to get a shot.

Leading scientists and doctors have called on authorities to release efficacy data about Covaxin to boost confidence about the vaccine.

Read: Criticism mounts of India's 'abrupt' approval of local vaccine

Covaxin recipients on Saturday had to sign a consent form that stated its “clinical efficacy [...] is yet to be established”.

Officials had hoped to inoculate 300,000 people on Saturday, but said glitches with an app used to coordinate and monitor the process meant not all potential recipients were alerted.

India has the world's second-largest known caseload with more than 10.5m coronavirus infections and over 152,000 deaths so far.

Opinion

Are we failures?
27 Feb 2021

Are we failures?

Third World leaders emulated their erstwhile oppressors...
Rage of Caliban
27 Feb 2021

Rage of Caliban

Lawyers have shown that the fraternity abides by tribalistic values...
Combating pollution
26 Feb 2021

Combating pollution

Air quality is at hazardous levels, and a more robust policy response is needed.

Editorial

LoC ceasefire
Updated 27 Feb 2021

LoC ceasefire

THE Pakistan-India relationship is known for its complexity and bitterness, but there are times when surprises of a...
27 Feb 2021

Null and void

HAD people not lost their lives, the ham-fisted attempt at rigging the Daska by-election on Feb 19 could have been...
27 Feb 2021

Minister’s non-appearance

FEDERAL Water Resources Minister Faisal Vawda’s continued absence from the Election Commission’s hearing on the...
Terrorist’s escape
Updated 26 Feb 2021

Terrorist’s escape

It is not clear how many military personnel were involved in this incident and what the investigation into their actions revealed.
26 Feb 2021

Penalising filers

THE FBR has decided to penalise taxpayers filing their returns late. Apparently, these filers will be required to ...
26 Feb 2021

Corporal punishment

FOR a child born in our society, the cycle of violence begins early. The first taste of violence often comes at the...